These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 19900216
1. Mutant presenilin-1 deregulated peripheral immunity exacerbates Alzheimer-like pathology. Zhu Y, Obregon D, Hou H, Giunta B, Ehrhart J, Fernandez F, Mori T, Nikolic W, Zhao Y, Morgan D, Town T, Tan J. J Cell Mol Med; 2011 Feb; 15(2):327-38. PubMed ID: 19900216 [Abstract] [Full Text] [Related]
6. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice. Liu L, Liu Y, Li N, Huang R, Zheng X, Huang L, Hou S, Yuan Q. Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120 [Abstract] [Full Text] [Related]
7. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao Ashe K, Hasegawa M, Mann DM, Hyman BT, Iwatsubo T. Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403 [Abstract] [Full Text] [Related]
13. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease. Campbell SN, Zhang C, Roe AD, Lee N, Lao KU, Monte L, Donohue MC, Rissman RA. J Alzheimers Dis; 2015 Jul; 45(4):1175-84. PubMed ID: 25697705 [Abstract] [Full Text] [Related]
16. Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention. Agca C, Klakotskaia D, Schachtman TR, Chan AW, Lah JJ, Agca Y. BMC Neurosci; 2016 Jul 07; 17(1):46. PubMed ID: 27388605 [Abstract] [Full Text] [Related]
17. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. Griciuc A, Federico AN, Natasan J, Forte AM, McGinty D, Nguyen H, Volak A, LeRoy S, Gandhi S, Lerner EP, Hudry E, Tanzi RE, Maguire CA. Hum Mol Genet; 2020 Oct 10; 29(17):2920-2935. PubMed ID: 32803224 [Abstract] [Full Text] [Related]
18. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease. Hansen HH, Fabricius K, Barkholt P, Kongsbak-Wismann P, Schlumberger C, Jelsing J, Terwel D, Termont A, Pyke C, Knudsen LB, Vrang N. PLoS One; 2016 Oct 10; 11(7):e0158205. PubMed ID: 27421117 [Abstract] [Full Text] [Related]
19. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM, King AE, Woodhouse A, Kirkcaldie MT, Vickers JC. Exp Neurol; 2015 May 10; 267():219-29. PubMed ID: 25747037 [Abstract] [Full Text] [Related]
20. A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity. Heilig EA, Xia W, Shen J, Kelleher RJ. J Biol Chem; 2010 Jul 16; 285(29):22350-9. PubMed ID: 20460383 [Abstract] [Full Text] [Related] Page: [Next] [New Search]